Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

NCT05443646 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Limited Stage Small Cell Lung Cancer

Interventions

DRUG: HLX10
RADIATION: hypofractionated radiotherapy
RADIATION: Prophylactic Cranial Irradiation (PCI)

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences